In a move warmly welcomed by parents and paediatric rheumatologists alike, the Pharmaceutical Benefits Scheme (PBS) is simplifying approvals for prescribing biologics and biosimilars. These
JAFA welcomes the Health Minister’s April 27, 2022 announcement of the largest-ever research funding allocation
This ground-breaking Inquiry was instigated by JAFA and conducted by the House of Representatives Standing
Victoria Allen, the inaugural Chair of Juvenile Arthritis Foundation Australia (JAFA) will retire from the
March 8, 2022 saw an historic landmark for Juvenile Arthritis /childhood rheumatic diseases (JA/CRDs) in
Since it’s inception JAFA with many parents, grandparents and friends, have actively been advocating the
JAFA’s Pre Election Campaign to Change Lives: Stop Pain and Disability in Children with Arthritis.